STERIS’ (TSE:STE – Free Report) – Investment analysts at Raymond James decreased their FY2025 earnings per share estimates for STERIS’ in a research report issued on Wednesday, March 12th. Raymond James analyst M. Barth now expects that the company will post earnings per share of $0.64 for the year, down from their prior estimate of $0.76. Raymond James also issued estimates for STERIS’’s FY2029 earnings at $0.68 EPS.
Several other equities research analysts have also issued reports on STE. Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a report on Sunday, December 22nd. Cormark upgraded STERIS’ to a “moderate buy” rating in a report on Monday, January 6th.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Recommended Stories
- Five stocks we like better than STERIS’
- Investing in the High PE Growth Stocks
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- How to Calculate Options Profits
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Insider Selling Explained: Can it Inform Your Investing Choices?
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
